The long-term efficacy of pulmonary allografts is better than that of aortic allografts ... should be stretched as straight as possible to increase the height of the semilunar valve. If the proximal ...
In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...
Medtronic plc and Tempus AI Inc. launched the ALERT study to better understand and address the racial, ethnic, gender and geographic disparities associated with guideline-recommended treatments for ...
Oral anticoagulation is recommended after ablation for atrial fibrillation among patients at high risk for stroke. Left atrial appendage closure is a mechanical alternative to anticoagulation ...
The RHEIA trial studied women with severe aortic stenosis and found that participants preferred transcatheter aortic valve replacement over surgical valve replacement.
The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...
JenaValve announced today that it received the green light to begin a new randomized controlled trial for its Trilogy device.
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...
Aortic regurgitation occurs when blood leaks back into the left ventricle due to a leaky aortic valve. This is a type of valve disease in the heart. Aortic regurgitation can lead to some heart ...
AF is frequently associated with mitral valve repair and modern surgery for MR often includes therapy for AF. Preoperative AF may impact the outcomes of patients undergoing mitral repair surgery ...
Citation: Early transcatheter aortic valve replacement can be beneficial for asymptomatic severe aortic stenosis patients: Study (2024, October 29) retrieved 17 November 2024 from https ...
Data from randomized trials examining whether early intervention with transcatheter aortic-valve replacement (TAVR) will improve outcomes in these patients are lacking. At 75 centers in the United ...